Among these, two FDA-approved drugs, disulfiram and diroximel fumarate (DMF), which are used for the treatment of alcohol dependence and relapsing multiple sclerosis, respectively, have been proven to be efficacious GSDMD inhibitors [48,49]. The gene discussed is GSDMD; the disease is alcohol dependence.